Gastrodia remodels intestinal microflora to suppress inflammation in mice with early atherosclerosis

Fei-Yu Liu,Jing Wen,Jiong Hou,Si-Qi Zhang,Chun-Bin Sun,Luo-Chuan Zhou,Wen Yin,Wen-Lin Pang,Cui Wang,Yi Ying,Si-Si Han,Jin-Yuan Yan,Chen-Xi Li,Jia-Li Yuan,Hai-Jing Xing,Zhong-Shan Yang
DOI: https://doi.org/10.1016/j.intimp.2021.107758
IF: 5.714
2021-07-01
International Immunopharmacology
Abstract:<p>Atherosclsis is a critical actuator causing cardiac-cerebral vascular disease with a complicated pathogeneon, refered to the disorders of intestinal flora and persistent inflammation. Gastrodin (4-(hydroxymethyl) phenyl-β-D- Glucopyranoside) is the most abundant glucoside extracted from the Gastrodia elata, which is a traditional Chinese herbal medicine for cardiac-cerebral vascular disease, yet its mechanisms remain little known. In the present study, the gastrodia extract and gastrodin attenuate the lipid deposition and foam cells on the inner membrane of the inner membrane of the thoracic aorta in the early atherosclerosis mice. Blood lipid detection tips that TC and LDL-C were reduced in peripheral blood after treatment with the gastrodia extract and gastrodin. Furthermore, unordered gut microbes are remodeled in terms of bacterial diversity and abundance at family and genus level. Also, the intestinal mucosa damage and permeability were reversed, accompanied with the reducing of inflammatory cytokines. Our findings revealed that the functions of gastrodia extract and gastrodin in cardiac-cerebral vascular disease involved to rescued gut microbes and anti-inflammation may be the mechanism of remission lipid accumulation.</p>
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?